ATNM

MKT CAP:$37M

Actinium Pharmaceuticals Inc

Market Cap

$37M

Healthcare·Biotechnology·🇺🇸 United States·AMEX

Healthcare·Biotechnology·🇺🇸·AMEX

Stock Price

$1.08-$0.29 (-21.17%)

Jun 5, 2026

52W High $1.9452W Low $0.98

Company Details

Actinium Pharmaceuticals, Inc. develops antibody radiation conjugates and other targeted radiotherapies intended to improve outcomes for people who have failed existing oncology therapies. The company offers Actimab-A, a CD33 targeting radi...

CEO

—

IPO Date

Dec 27, 2012

Website

www.actiniumpharma.com

Key Metrics TTM

Revenue

$90.0K

-88.9% YoY

Net Income

-$23M

EPS (Diluted)

Free Cash Flow

-$23M

Revenue / Share

$0.00

Gross Margin

312.2%

Operating Margin

-28346.7%

Net Margin

-26078.9%

FCF Margin

-25535.6%

P/S

411.4x

P/E

Earnings Reports

Q1 2026

May 8, 2026

FY 2025

Mar 30, 2026

$90.0K

Q4 2025

Mar 30, 2026

$0-100.0%

Q3 2025

Nov 14, 2025

$90.0K

Q2 2025

Aug 8, 2025

Revenue & Profitability

Valuation

Operating Cash Flow

CapEx Spend

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

War Chest

Shares Outstanding

Revenue Per Employee

Revenue / Employee